Table 2.
Sample size National estimate |
Women n=2319 n=16 880 659 |
Men n=1833 n=12 849 486 |
P value |
---|---|---|---|
Triage level, % (95% CI) | <0.001 | ||
Immediate/emergent | 19.1% (15.8%–22.8%) | 23.3% (19.3%–27.9%) | |
Urgent | 38.0% (33.6%–42.8%) | 39.6% (34.9%–44.6%) | |
Semiurgent/nonurgent | 12.8% (10.0%–16.3%) | 7.5% (5.5%–10.1%) | |
No triage | 30.1% (23.4%–37.8%) | 29.5% (23.5%–36.3%) | |
Diagnostic testing, % (95% CI) | |||
BNP | 6.6% (5.2%–8.3%) | 8.7% (7.0%–10.8%) | 0.032 |
Cardiac enzymes | 20.6% (16.8%–25.1%) | 22.9% (18.8%–27.5%) | 0.203 |
D‐dimer | 16.6% (14.2%–19.4%) | 11.9% (9.8%–14.3%) | 0.005 |
X‐ray | 71.4% (68.0%–74.6%) | 75.6% (72.8%–78.2%) | 0.041 |
Electrocardiography | 74.2% (71.0%–77.2%) | 78.8% (76.1%–81.3%) | 0.024 |
Cardiac monitor | 24.9% (21.7%–28.5%) | 30.0% (25.8%–34.5%) | 0.004 |
CT chest | 8.9% (7.6%–10.5%) | 8.2% (6.8%–9.9%) | 0.447 |
Toxicology screen | 3.9% (2.9%–5.2%) | 7.3% (5.9%–9.0%) | <0.001 |
No testing | 24.6% (21.2%–29.0%) | 22.3% (18.9%–26.3%) | 0.058 |
Seen by consulting physician | 8.5% (6.8%–10.5%) | 12.3% (9.8%–15.0%) | 0.001 |
Wait time to see provider, min, mean±SD † | 48.1±82.1 | 37.2±61.8 | <0.001 |
BNP indicates B‐type natriuretic peptide; and CT, computed tomography.
Percentages based on national estimates.
Means calculated among those with values >0; estimated number of emergency department visits for wait times were available: women: 14 706 262; men: 11 181 998.